Stock Track | METiS TECHBIO-P Plummets 5.15% Intraday as Post-IPO Enthusiasm Fades and Profit-Taking Pressure Mounts

Stock Track05-29

METiS TECHBIO-P's stock plummeted 5.15% during intraday trading on Friday, continuing a sustained retreat from its post-IPO highs.

The decline reflects multiple challenges facing the company, which remains in early commercialization stages with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue streams creating uncertainty about its growth outlook. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure as early investors exit positions.

Despite recent strategic developments including the launch of its AiProtein platform and a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, market enthusiasm has cooled rapidly following the company's initial public offering, sustaining downward pressure on the share price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1164605533?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-29 11:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164605533","market":"hk","top_or_hot":-1,"title":"Stock Track | METiS TECHBIO-P Plummets 5.15% Intraday as Post-IPO Enthusiasm Fades and Profit-Taking Pressure Mounts","media":"Stock Track","content":"<p>METiS TECHBIO-P's stock plummeted 5.15% during intraday trading on Friday, continuing a sustained retreat from its post-IPO highs.</p><p>The decline reflects multiple challenges facing the company, which remains in early commercialization stages with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue streams creating uncertainty about its growth outlook. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure as early investors exit positions.</p><p>Despite recent strategic developments including the launch of its AiProtein platform and a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, market enthusiasm has cooled rapidly following the company's initial public offering, sustaining downward pressure on the share price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | METiS TECHBIO-P Plummets 5.15% Intraday as Post-IPO Enthusiasm Fades and Profit-Taking Pressure Mounts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | METiS TECHBIO-P Plummets 5.15% Intraday as Post-IPO Enthusiasm Fades and Profit-Taking Pressure Mounts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-29 11:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>METiS TECHBIO-P's stock plummeted 5.15% during intraday trading on Friday, continuing a sustained retreat from its post-IPO highs.</p><p>The decline reflects multiple challenges facing the company, which remains in early commercialization stages with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue streams creating uncertainty about its growth outlook. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure as early investors exit positions.</p><p>Despite recent strategic developments including the launch of its AiProtein platform and a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, market enthusiasm has cooled rapidly following the company's initial public offering, sustaining downward pressure on the share price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1164605533","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164605533","pubTimestamp":1780024247,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"METiS TECHBIO-P's stock plummeted 5.15% during intraday trading on Friday, continuing a sustained retreat from its post-IPO highs.The decline reflects multiple challenges facing the company, which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"个股追踪|METiS TECHBIO-P盘中暴跌5.15%，IPO后热情消退，获利了结压力加大","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"METiS TECHBIO-P's stock plummeted 5.15% during intraday trading on Friday, continuing a sustained retreat from its post-IPO highs.The decline reflects multiple challenges facing the company, which remains in early commercialization stages with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue streams creating uncertainty about its growth outlook. Additionally, some internationally placed shares carry no lock-up period, generating persistent profit-taking pressure as early investors exit positions.Despite recent strategic developments including the launch of its AiProtein platform and a strategic alliance with Deerfield to co-develop next-generation in vivo protein therapeutics and immunotherapies, market enthusiasm has cooled rapidly following the company's initial public offering, sustaining downward pressure on the share price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1164605533","isCrawlerRequest":true}